Literature DB >> 29602394

The Warburg Effect in Diabetic Kidney Disease.

Guanshi Zhang1, Manjula Darshi1, Kumar Sharma2.   

Abstract

Diabetic kidney disease (DKD) is the leading cause of morbidity and mortality in diabetic patients. Defining risk factors for DKD using a reductionist approach has proven challenging. Integrative omics-based systems biology tools have shed new insights in our understanding of DKD and have provided several key breakthroughs for identifying novel predictive and diagnostic biomarkers. In this review, we highlight the role of the Warburg effect in DKD and potential regulating factors such as sphingomyelin, fumarate, and pyruvate kinase muscle isozyme M2 in shifting glucose flux from complete oxidation in mitochondria to the glycolytic pathway and its principal branches. With the development of highly sensitive instruments and more advanced automatic bioinformatics tools, we believe that omics analyses and imaging techniques will focus more on singular-cell-level studies, which will allow in-depth understanding of DKD and pave the path for personalized kidney precision medicine. Published by Elsevier Inc.

Entities:  

Keywords:  Diabetic kidney disease; aerobic glycolysis; metabolomics; mitochondrion; the Warburg effect

Mesh:

Substances:

Year:  2018        PMID: 29602394      PMCID: PMC5973839          DOI: 10.1016/j.semnephrol.2018.01.002

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  84 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  PKM2, cancer metabolism, and the road ahead.

Authors:  Talya L Dayton; Tyler Jacks; Matthew G Vander Heiden
Journal:  EMBO Rep       Date:  2016-11-17       Impact factor: 8.807

3.  Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy.

Authors:  Atsuyuki Shimazaki; Yoshihiro Kawamura; Akio Kanazawa; Akihiro Sekine; Susumu Saito; Tatsuhiko Tsunoda; Daisuke Koya; Tetsuya Babazono; Yasushi Tanaka; Masafumi Matsuda; Koichi Kawai; Tomohiro Iiizumi; Masahito Imanishi; Toshihiro Shinosaki; Toru Yanagimoto; Minoru Ikeda; Shigeki Omachi; Atsunori Kashiwagi; Kohei Kaku; Yasuhiko Iwamoto; Ryuzou Kawamori; Ryuichi Kikkawa; Masatoshi Nakajima; Yusuke Nakamura; Shiro Maeda
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

Review 4.  Endothelin, nitric oxide, and reactive oxygen species in diabetic kidney disease.

Authors:  Jennifer S Pollock; David M Pollock
Journal:  Contrib Nephrol       Date:  2011-08-30       Impact factor: 1.580

5.  Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications.

Authors:  Kelli M Sas; Pradeep Kayampilly; Jaeman Byun; Viji Nair; Lucy M Hinder; Junguk Hur; Hongyu Zhang; Chengmao Lin; Nathan R Qi; George Michailidis; Per-Henrik Groop; Robert G Nelson; Manjula Darshi; Kumar Sharma; Jeffrey R Schelling; John R Sedor; Rodica Pop-Busui; Joel M Weinberg; Scott A Soleimanpour; Steven F Abcouwer; Thomas W Gardner; Charles F Burant; Eva L Feldman; Matthias Kretzler; Frank C Brosius; Subramaniam Pennathur
Journal:  JCI Insight       Date:  2016-09-22

6.  Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle.

Authors:  Marek Straczkowski; Irina Kowalska; Agnieszka Nikolajuk; Stella Dzienis-Straczkowska; Ida Kinalska; Marcin Baranowski; Malgorzata Zendzian-Piotrowska; Zofia Brzezinska; Jan Gorski
Journal:  Diabetes       Date:  2004-05       Impact factor: 9.461

Review 7.  PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

Review 8.  Diabetic kidney disease.

Authors:  Merlin C Thomas; Michael Brownlee; Katalin Susztak; Kumar Sharma; Karin A M Jandeleit-Dahm; Sophia Zoungas; Peter Rossing; Per-Henrik Groop; Mark E Cooper
Journal:  Nat Rev Dis Primers       Date:  2015-07-30       Impact factor: 52.329

Review 9.  Technical advances in global DNA methylation analysis in human cancers.

Authors:  Basudev Chowdhury; Il-Hoon Cho; Joseph Irudayaraj
Journal:  J Biol Eng       Date:  2017-03-01       Impact factor: 4.355

10.  Maintenance of endothelial guanosine triphosphate cyclohydrolase I ameliorates diabetic nephropathy.

Authors:  Kengo Kidokoro; Minoru Satoh; Keith M Channon; Toyotaka Yada; Tamaki Sasaki; Naoki Kashihara
Journal:  J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 10.121

View more
  26 in total

1.  Glycolysis inhibitors suppress renal interstitial fibrosis via divergent effects on fibroblasts and tubular cells.

Authors:  Qingqing Wei; Jennifer Su; Guie Dong; Ming Zhang; Yuqing Huo; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-10

2.  Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules.

Authors:  Jinpeng Li; Haijie Liu; Susumu Takagi; Kyoko Nitta; Munehiro Kitada; Swayam Prakash Srivastava; Yuta Takagaki; Keizo Kanasaki; Daisuke Koya
Journal:  JCI Insight       Date:  2020-03-26

3.  The effect of hyperbaric oxygen on mitochondrial and glycolytic energy metabolism: the caloristasis concept.

Authors:  Didem Tezgin; Charles Giardina; George A Perdrizet; Lawrence E Hightower
Journal:  Cell Stress Chaperones       Date:  2020-04-06       Impact factor: 3.667

Review 4.  Role of Glucose Metabolism and Mitochondrial Function in Diabetic Kidney Disease.

Authors:  Robert C Stanton
Journal:  Curr Diab Rep       Date:  2021-01-15       Impact factor: 4.810

Review 5.  Fructose Production and Metabolism in the Kidney.

Authors:  Takahiko Nakagawa; Richard J Johnson; Ana Andres-Hernando; Carlos Roncal-Jimenez; Laura G Sanchez-Lozada; Dean R Tolan; Miguel A Lanaspa
Journal:  J Am Soc Nephrol       Date:  2020-04-06       Impact factor: 10.121

Review 6.  Immunometabolic rewiring of tubular epithelial cells in kidney disease.

Authors:  Sanne van der Rijt; Jaklien C Leemans; Sandrine Florquin; Riekelt H Houtkooper; Alessandra Tammaro
Journal:  Nat Rev Nephrol       Date:  2022-07-07       Impact factor: 42.439

Review 7.  Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches.

Authors:  Munehiro Kitada; Taro Hirai; Daisuke Koya
Journal:  Diabetol Int       Date:  2020-06-11

8.  ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.

Authors:  G Michelle Ducasa; Alla Mitrofanova; Shamroop K Mallela; Xiaochen Liu; Judith Molina; Alexis Sloan; Christopher E Pedigo; Mengyuan Ge; Javier Varona Santos; Yanio Hernandez; Jin-Ju Kim; Cyrille Maugeais; Armando J Mendez; Viji Nair; Matthias Kretzler; George W Burke; Robert G Nelson; Yu Ishimoto; Reiko Inagi; Santanu Banerjee; Shaoyi Liu; Hazel H Szeto; Sandra Merscher; Flavia Fontanesi; Alessia Fornoni
Journal:  J Clin Invest       Date:  2019-07-22       Impact factor: 19.456

9.  Mitochondrial pyruvate carrier: a potential target for diabetic nephropathy.

Authors:  Huanhuan Zhu; Huiting Wan; Lin Wu; Qing Li; Simeng Liu; Suyan Duan; Zhimin Huang; Chengning Zhang; Bo Zhang; Changying Xing; Yanggang Yuan
Journal:  BMC Nephrol       Date:  2020-07-14       Impact factor: 2.388

10.  The diabetic microenvironment causes mitochondrial oxidative stress in glomerular endothelial cells and pathological crosstalk with podocytes.

Authors:  Gabriella A Casalena; Liping Yu; Roberto Gil; Samuel Rodriguez; Shantel Sosa; William Janssen; Evren U Azeloglu; Jeremy S Leventhal; Ilse S Daehn
Journal:  Cell Commun Signal       Date:  2020-07-08       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.